WCM Investment Management Portfolio holdings
AUM
$43.8B
This Quarter Return
+3.13%
1 Year Return
+46.92%
3 Year Return
+145.55%
5 Year Return
+234.7%
10 Year Return
+793.48%
AUM
$36.5B
AUM Growth
+$36.5B
(-0.74%)
Cap. Flow
-$619M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
65.11%
Holding
210
New
17
Increased
114
Reduced
56
Closed
20
Top Buys
| 1 |
Old Dominion Freight Line
ODFL
|
$276M |
| 2 |
Nike
NKE
|
$129M |
| 3 |
HDFC Bank
HDB
|
$82.6M |
| 4 |
Ferrari
RACE
|
$60.8M |
| 5 |
ASML
ASML
|
$57.2M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$1.02B |
| 2 |
Idexx Laboratories
IDXX
|
$320M |
| 3 |
Verisk Analytics
VRSK
|
$264M |
| 4 |
Intercontinental Exchange
ICE
|
$208M |
| 5 |
ANSS
Ansys
ANSS
|
$184M |
Sector Composition
| 1 | Technology | 34.7% |
| 2 | Healthcare | 21.24% |
| 3 | Consumer Discretionary | 14.67% |
| 4 | Financials | 12.98% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWAV
126
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $7.49M | 0.02% |
57,500
-27,798
| -33% | -$3.62M |
|
|
MDLA
127
DELISTED
Medallia, Inc.
MDLA
| $7.4M | 0.02% |
265,297
-46,533
| -15% | -$1.3M |
|
128
Fate Therapeutics
FATE
$115M
| $7.37M | 0.02% |
89,424
-4,765
| -5% | -$393K |
|
129
CryoPort
CYRX
$426M
| $6.99M | 0.02% |
134,396
+47,613
| +55% | +$2.48M |
|
130
Charles River Laboratories
CRL
$7.99B
| $6.79M | 0.02% |
23,440
-25,514
| -52% | -$7.4M |
|
131
BridgeBio Pharma
BBIO
$9.91B
| $6.49M | 0.02% |
105,428
-36,421
| -26% | -$2.24M |
|
132
Tandem Diabetes Care
TNDM
$834M
| $6.19M | 0.02% |
70,151
-1,957
| -3% | -$173K |
|
|
NSTG
133
DELISTED
NanoString Technologies, Inc.
NSTG
| $6.1M | 0.02% |
92,872
-2,177
| -2% | -$143K |
|
134
Arrowhead Research
ARWR
$3.84B
| $5.57M | 0.02% |
84,049
-67,846
| -45% | -$4.5M |
|
135
Halozyme
HALO
$8.75B
| $5.42M | 0.01% |
129,923
-2,527
| -2% | -$105K |
|
|
BHVN
136
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.4M | 0.01% |
78,942
-1,716
| -2% | -$117K |
|
137
Insmed
INSM
$30.3B
| $5.22M | 0.01% |
153,149
-2,930
| -2% | -$99.8K |
|
|
TPTX
138
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.94M | 0.01% |
52,231
-1,085
| -2% | -$103K |
|
139
Tradeweb Markets
TW
$27.1B
| $4.75M | 0.01% |
64,170
+4,204
| +7% | +$311K |
|
140
Ligand Pharmaceuticals
LGND
$3.25B
| $4.4M | 0.01% |
28,826
-38,818
| -57% | -$5.92M |
|
141
Rocket Pharmaceuticals
RCKT
$358M
| $4.13M | 0.01% |
92,990
-2,145
| -2% | -$95.2K |
|
|
RETA
142
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $4.08M | 0.01% |
40,959
+14,647
| +56% | +$1.46M |
|
143
Axsome Therapeutics
AXSM
$6.09B
| $4M | 0.01% |
70,664
-1,443
| -2% | -$81.7K |
|
|
ANSS
144
DELISTED
Ansys
ANSS
| $3.73M | 0.01% |
10,981
-541,734
| -98% | -$184M |
|
145
Acadia Pharmaceuticals
ACAD
$4.34B
| $3.35M | 0.01% |
129,864
+56,330
| +77% | +$1.45M |
|
146
Amazon
AMZN
$2.41T
| $3.31M | 0.01% |
1,069
+7
| +0.7% | +$21.7K |
|
147
Netflix
NFLX
$521B
| $3.13M | 0.01% |
6,000
| – | – |
|
148
Simulations Plus
SLP
$289M
| $2.54M | 0.01% |
40,078
| – | – |
|
149
Iovance Biotherapeutics
IOVA
$800M
| $2.13M | 0.01% |
67,145
-87,945
| -57% | -$2.78M |
|
|
CDK
150
DELISTED
CDK Global, Inc.
CDK
| $1.6M | ﹤0.01% |
29,616
+8,734
| +42% | +$472K |
|